cisplatin, nivolumab
Nivolumab oo ay weheliso cisplatin iyo gemcitabine waxa ay USFDA u ansixisay kansarka kaadi mareenka ee aan la dabar goyn ama metastatic.
Maarso 2024: Maamulka Cuntada iyo Dawooyinka ayaa oggolaaday isticmaalka nivolumab (Opdivo, Bristol-Myers Squibb Company) iyada oo lala kaashanayo cisplatin iyo gemcitabine oo ah daawaynta ugu horreysa ee bukaannada qaangaarka ah ee qaba cillad la'aan.
Pembrolizumab, USFDA
Enfortumab vedotin-ejfv oo leh pembrolizumab waxa u ansixisay USFDA kansarka urothelial urothelial ee horumarsan ama metastatic
Feb 2024: Maamulka Cuntada iyo Dawooyinka ayaa dadajiyay nidaamka oggolaanshaha ee laba daawo, enfortumab vedotin-ejfv (Padcev, Astellas Pharma) iyo pembrolizumab (Keytruda, Merck). Daawooyinkan waxaa loogu talagalay in lagu daweeyo dadka deegaanka ..
Bristol Myers Squibb, CHEKMATE-274, nivolumab, Cajiib, Kansarka qanjirka 'Urothelial'
Nivolumab waxaa ansixiyay FDA si loogu isticmaalo sidii daaweyn wax ku ool ah kansarka urothelial
Ogosto 2021: Nivolumab (Opdivo, Bristol-Myers Squibb Co.) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka si loogu daweeyo bukaanada qaba kansarka kaadi mareenka (UC) kuwaas oo qatar weyn ugu jira soo noqnoqoshada rad.
Astellas Pharma US, NCT03474107, Padcev, Tijaabada EV-301
FDA waxay siisay enfortumab vedotin-ejfv oggolaanshaha daaweynta kansarka urothelial maxalliga ah ama metastatic
Ogosto 2021: Enfortumab vedotin-ejfv (Padcev, Astellas Pharma US, Inc.), Nectin-4-antibody-antibody iyo microtubule inhibitor inhibitor, waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka bukaanada qaangaarka ah
Immunomedics Inc., mUC, kiimoterabi oo ay ku jirto platinum, soo-dhoweeyaha barnaamijka-1, sacituzumab govitecan, Trodelvy, Trophy
Govitecan Sacituzumab wuxuu oggolaansho deg deg ah ka helaa FDA kansarka kaadi mareenka ee horumarsan
Ogosto 2021: Sacituzumab govitecan (Trodelvy, Immunomedics Inc.) ayaa Maamulka Cuntada iyo Dawooyinka siisay oggolaansho degdeg ah bukaannada qaba kansarka urothelial -ka maxalliga ah ama metastatic urothelial (mUC) oo hore u qaatay.